Aishwarya Srivastava

Aishwarya Srivastava is an accomplished Senior Scientist at US WorldMeds, with extensive experience in T-Cell Process & Analytical Development from prior roles at Adaptimmune and TCR² Therapeutics Inc. Aishwarya's expertise includes functional genomics, having contributed to CRISPR screening for gamma delta T cell therapy at Merck. Academic credentials include a Master of Science in Biomedical Sciences from Northeastern University and a Master of Technology in Biotechnology from Dr. D. Y. Patil Vidyapeeth. Aishwarya's early career involved various research and training positions, emphasizing molecular medicine and cancer therapy.